CAR-T Cell Therapy

Nature Papers Identify RHOG and CDKN1B as In Vivo Boosters for CAR T Cells

The in vivo data sharpen the path from CRISPR discovery to clinical translation by revealing which edits actually sustain CAR T cells in tumors.